HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.

Abstract
Nodakenin, a coumarin isolated from the roots of Angelicae gigas, has been reported to possess neuroprotective, antiaggregatory, antibacterial, and memory-enhancing effects. In the present study, we investigated the anti-inflammatory effects of nodakenin by examining its in vitro inhibitory effects on inducible nitric-oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and proinflammatory cytokines in lipopolysaccharide (LPS)-induced RAW 264.7 macrophages and mouse peritoneal macrophages and its in vivo effects on LPS-induced septic shock in mice. Our results indicate that nodakenin concentration-dependently inhibits iNOS and COX-2 at the protein, mRNA, and promoter binding levels, and these inhibitions cause attendant decreases in the production of nitric oxide (NO) and prostaglandin E₂ (PGE₂). Furthermore, we found that nodakenin inhibits the production and mRNA expression of tumor necrosis factor-α (TNF-α), interleukin (IL)-6, and IL-1β induced by LPS. Molecular data revealed that nodakenin suppressed the transcriptional activity and translocation of nuclear factor-κB (NF-κB) by inhibiting inhibitory κB-α degradation and IκB kinase-α/β phosphorylation. In addition, nodakenin was found to significantly inhibit the LPS-induced binding of transforming growth factor-β-activated kinase 1 to tumor necrosis factor receptor-associated factor 6 (TRAF6) by reducing TRAF6 ubiquitination. Pretreatment with nodakenin reduced the serum levels of NO, PGE₂, and proinflammatory cytokines and increased the survival rate of mice with LPS-induced endotoxemia. Taken together, our data suggest that nodakenin down-regulates the expression of the proinflammatory iNOS, COX-2, TNF-α, IL-6, and IL-1β genes in macrophages by interfering with the activation of TRAF6, thus preventing NF-κB activation.
AuthorsHong-Kun Rim, Woong Cho, Sang Hyun Sung, Kyung-Tae Lee
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 342 Issue 3 Pg. 654-64 (Sep 2012) ISSN: 1521-0103 [Electronic] United States
PMID22637723 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents
  • Coumarins
  • Glucosides
  • I-kappa B Proteins
  • Interleukin-1beta
  • Interleukin-6
  • Lipopolysaccharides
  • NF-kappa B
  • TNF Receptor-Associated Factor 6
  • Tumor Necrosis Factor-alpha
  • NF-kappaB inhibitor alpha
  • Nitric Oxide
  • nodakenin
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • I-kappa B Kinase
  • MAP Kinase Kinase Kinases
  • MAP kinase kinase kinase 7
  • Mitogen-Activated Protein Kinase Kinases
  • Dinoprostone
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Cells, Cultured
  • Coumarins (pharmacology)
  • Cyclooxygenase 2 (genetics, metabolism)
  • Dinoprostone (antagonists & inhibitors, genetics, metabolism)
  • Down-Regulation (drug effects, genetics)
  • Drug Interactions
  • Glucosides (pharmacology)
  • I-kappa B Kinase (antagonists & inhibitors, genetics, metabolism)
  • I-kappa B Proteins (antagonists & inhibitors, genetics, metabolism)
  • Inflammation (drug therapy, genetics, metabolism)
  • Interleukin-1beta (antagonists & inhibitors, genetics, metabolism)
  • Interleukin-6 (antagonists & inhibitors, genetics, metabolism)
  • Lipopolysaccharides (pharmacology)
  • MAP Kinase Kinase Kinases (genetics, metabolism)
  • Macrophages (drug effects, metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mitogen-Activated Protein Kinase Kinases (antagonists & inhibitors, genetics, metabolism)
  • NF-kappa B (antagonists & inhibitors, genetics, metabolism)
  • Nitric Oxide (antagonists & inhibitors, genetics, metabolism)
  • Nitric Oxide Synthase Type II (antagonists & inhibitors, genetics, metabolism)
  • Phosphorylation (drug effects, genetics)
  • Promoter Regions, Genetic (drug effects)
  • Shock, Septic (drug therapy, metabolism, prevention & control)
  • Signal Transduction (drug effects, genetics)
  • TNF Receptor-Associated Factor 6 (antagonists & inhibitors, genetics, metabolism)
  • Transcription, Genetic (drug effects, genetics)
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors, genetics, metabolism)
  • Ubiquitination (drug effects, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: